Twinrix Adult (hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed))
- Region
- 🇪🇺 EU
- Active substance
- hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
- Company
- GlaxoSmithKline Biologicals S.A.
- Status
- Authorised
- Therapeutic area
- Hepatitis B; Hepatitis A; Immunization
- EU approval
- Thu 19 Sep 1996
- Application
- EMEA/H/C/000112
- ATC
- J07BC20
- Official record
- www.ema.europa.eu
Indication
Twinrix Adult is indicated for use in non immune adults and adolescents 16 years of age and above who are at risk of both hepatitis A and hepatitis B infection.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Twinrix Paediatric Authorised · GlaxoSmithKline Biologicals S.A.
- 🇪🇺 Ambirix Authorised · GlaxoSmithKline Biologicals S.A.
Follow Twinrix Adult
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.